Full Press Release Details
WARSAW, Ind.,July 13, 2026/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.
A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website athttps://investor.zimmerbiomet.com. It will be available for replay following the conference call.
Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (800) 330-6710 and using conference ID 7090861. International callers should dial +1 (213) 279-1505 and use conference ID 7090861.
About Zimmer BiometZimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visitwww.zimmerbiomet.comor follow on LinkedIn atwww.linkedin.com/company/zimmerbiometor X atwww.x.com/zimmerbiomet.
| Contacts:MediaTroy Kirkpatrick614-284-1926[email protected]Kirsten Fallon781-779-5561[email protected] | InvestorsDavid DeMartino646-531-6115[email protected]Zach Weiner908-591-6955[email protected] |
Media
Troy Kirkpatrick
614-284-1926
[email protected]
Kirsten Fallon
781-779-5561[email protected]
Investors
David DeMartino
646-531-6115
[email protected]
Zach Weiner
908-591-6955
[email protected]